반응식
[Cl:1][C:2]1[N:3]=[N:4][C:5]([C:8]2[CH:13]=[CH:12][C:11]([C:14]([F:17])([F:16])[F:15])=[CH:10][CH:9]=2)=[CH:6][CH:7]=1.[CH3:18][N:19]([CH3:29])[CH2:20][CH2:21][CH2:22][N:23]1[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]1>>[ClH:1].[ClH:1].[CH3:29][N:19]([CH3:18])[CH2:20][CH2:21][CH2:22][N:23]1[CH2:24][CH2:25][N:26]([C:2]2[N:3]=[N:4][C:5]([C:8]3[CH:13]=[CH:12][C:11]([C:14]([F:17])([F:16])[F:15])=[CH:10][CH:9]=3)=[CH:6][CH:7]=2)[CH2:27][CH2:28]1참가 물질
3
실험 절차
The title compound was prepared by a similar procedure to that described in Example 1, starting from 3-chloro-6-(4-trifluoromethylphenyl)pyridazine and (3-dimethylaminoprop-1-yl)piperazine.
출처 및 근거
- ORD 기록
- ord-bff784a44e7047a5b87411598c00cd60
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08846677B2
연결된 노트
불러오는 중…